• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在ChromaFlo成像引导下经皮冠状动脉介入治疗极早期大隐静脉移植血管动脉瘤

Very early great saphenous vein graft aneurysm treated by percutaneous coronary intervention under ChromaFlo imaging guidance.

作者信息

Yamaguchi Tetsuo, Miyamoto Takamichi, Kawahatsu Kandoh, Nozato Toshihiro

机构信息

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

出版信息

BMJ Case Rep. 2017 Jul 19;2017:bcr-2017-220443. doi: 10.1136/bcr-2017-220443.

DOI:10.1136/bcr-2017-220443
PMID:28729378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5535046/
Abstract

A 73-year-old man, who had undergone coronary artery bypass grafting (CABG) 10 days prior, presented with a great saphenous vein graft aneurysm (SVGA). CT revealed the increasing size of the aneurysm. Since the SVGA occurred immediately after CABG and there were no other complications, the aneurysm was treated percutaneously. While intravascular ultrasonography (IVUS) and optical coherence tomography failed to detect the entry point, an IVUS catheter with the addition of ChromaFlo imaging clearly revealed the entry point, size and length of the SVGA. To prevent migration and edge restenosis associated with covered stents, the covered stent (3.0×19 mm) was superimposed on a drug-eluting stent (3.0×28 mm) that covered the entry site. A follow-up study demonstrated the absence of flow into the aneurysm.

摘要

一名73岁男性,10天前接受了冠状动脉旁路移植术(CABG),出现了大隐静脉移植血管动脉瘤(SVGA)。CT显示动脉瘤大小在增加。由于SVGA在CABG后立即出现且无其他并发症,遂对该动脉瘤进行了经皮治疗。虽然血管内超声(IVUS)和光学相干断层扫描未能检测到入口点,但添加了ChromaFlo成像的IVUS导管清晰地显示了SVGA的入口点、大小和长度。为防止与覆膜支架相关的移位和边缘再狭窄,将覆膜支架(3.0×19毫米)叠加在覆盖入口部位的药物洗脱支架(3.0×28毫米)上。一项随访研究表明动脉瘤内无血流。

相似文献

1
Very early great saphenous vein graft aneurysm treated by percutaneous coronary intervention under ChromaFlo imaging guidance.在ChromaFlo成像引导下经皮冠状动脉介入治疗极早期大隐静脉移植血管动脉瘤
BMJ Case Rep. 2017 Jul 19;2017:bcr-2017-220443. doi: 10.1136/bcr-2017-220443.
2
Percutaneous treatment of a massive saphenous vein graft aneurysm.经皮治疗巨大隐静脉移植物动脉瘤。
Catheter Cardiovasc Interv. 2019 Apr 1;93(5):923-926. doi: 10.1002/ccd.28040. Epub 2018 Dec 27.
3
Impending rupture of saphenous vein graft aneurysm with floating fractured bare metal stent treated by coil embolization and covered stent implantation.采用弹簧圈栓塞和覆膜支架植入术治疗伴有漂浮断裂裸金属支架的大隐静脉移植血管动脉瘤即将破裂。
Heart Vessels. 2016 Nov;31(11):1882-1885. doi: 10.1007/s00380-016-0799-9. Epub 2016 Jan 27.
4
Stent-graft repair of a giant saphenous vein graft aneurysm.支架-移植物修复巨大的隐静脉移植物动脉瘤。
Heart Lung Circ. 2012 Dec;21(12):828-30. doi: 10.1016/j.hlc.2012.04.018. Epub 2012 Jun 27.
5
[Aneurysm of a saphenous vein aortocoronary graft. Apropos of a case presenting with a presternal mass and review of the literature].[大隐静脉主动脉冠状动脉移植血管的动脉瘤。关于一例出现胸骨前肿块的病例及文献复习]
Ann Chir. 1991;45(8):657-60.
6
Percutaneous treatment of saphenous vein graft aneurysm: Contemporary procedural considerations.经皮治疗隐静脉移植物动脉瘤:当代治疗方案的考虑因素。
Catheter Cardiovasc Interv. 2019 Apr 1;93(5):927-932. doi: 10.1002/ccd.28128. Epub 2019 Feb 9.
7
Saphenous Vein Graft Aneurysm: A Case-Based Review of Percutaneous Management.大隐静脉移植血管动脉瘤:基于病例的经皮治疗综述
Cardiovasc Revasc Med. 2019 Dec;20(12):1190-1195. doi: 10.1016/j.carrev.2019.01.029. Epub 2019 Feb 8.
8
Saphenous vein graft aneurysm after coronary artery bypass grafting.冠状动脉旁路移植术后大隐静脉移植血管动脉瘤
Ann Thorac Cardiovasc Surg. 2009 Feb;15(1):61-3.
9
Long-term outcome of percutaneous exclusion of huge saphenous vein graft aneurysms using peripheral covered-stents as alternative to surgical repair.使用外周覆膜支架经皮封堵巨大隐静脉移植血管瘤作为手术修复替代方法的长期疗效
J Invasive Cardiol. 2012 Dec;24(12):689-91.
10
Surgical treatment for saphenous vein graft aneurysm without redo sternotomy.不进行再次胸骨切开术的大隐静脉移植血管动脉瘤的外科治疗
J Card Surg. 2020 Apr;35(4):946-949. doi: 10.1111/jocs.14485. Epub 2020 Mar 1.

本文引用的文献

1
Giant saphenous vein graft aneurysm presenting as ST-elevation myocardial infarction.表现为ST段抬高型心肌梗死的大隐静脉移植血管动脉瘤
Circ J. 2014;78(3):769-71. doi: 10.1253/circj.cj-13-1054. Epub 2013 Nov 27.
2
Natural history and management of aortocoronary saphenous vein graft aneurysms: a systematic review of published cases.主动脉冠状动脉大隐静脉移植动脉瘤的自然病史与治疗:已发表病例的系统评价
Circulation. 2012 Oct 30;126(18):2248-56. doi: 10.1161/CIRCULATIONAHA.112.101592.
3
Giant coronary artery aneurysm: imaging findings before and after treatment with a polytetrafluoroethylene-covered stent.巨大冠状动脉瘤:聚四氟乙烯覆膜支架治疗前后的影像学表现
Circ Cardiovasc Interv. 2008 Aug;1(1):85-6. doi: 10.1161/CIRCINTERVENTIONS.107.763656.
4
Surgical treatment of saphenous vein graft aneurysms after coronary artery revascularization.冠状动脉血运重建后隐静脉移植物动脉瘤的外科治疗。
Ann Thorac Surg. 2009 Dec;88(6):1801-5. doi: 10.1016/j.athoracsur.2009.07.048.
5
Delayed endothelialization after polytetrafluoroethylene-covered stent implantation for coronary aneurysm.聚四氟乙烯覆膜支架植入治疗冠状动脉瘤后内皮化延迟
Circ J. 2009 Jan;73(1):190-3. doi: 10.1253/circj.cj-07-0924. Epub 2008 Nov 11.
6
Giant saphenous vein graft pseudoaneurysm rupture presenting with cardiac tamponade.大隐静脉移植血管假性动脉瘤破裂并伴有心脏压塞。
Heart Lung Circ. 2009 Feb;18(1):52-4. doi: 10.1016/j.hlc.2007.10.002. Epub 2008 Jan 31.
7
Staged stenting of a long aneurysm of a saphenous vein coronary artery bypass graft.分期支架置入治疗大隐静脉冠状动脉旁路移植血管的长动脉瘤
J Invasive Cardiol. 2008 Jan;20(1):E1-5.
8
Large saphenous vein graft aneurysm with a fistula to the right atrium.大隐静脉移植血管瘤并伴有右心房瘘。
Ann Thorac Cardiovasc Surg. 2006 Dec;12(6):435-7.
9
Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction.覆膜Wallstent治疗远端恶性胆管梗阻患者的疗效与安全性。
Gastrointest Endosc. 2005 Nov;62(5):742-8. doi: 10.1016/j.gie.2005.06.030.
10
Polytetrafluoroethylene stent deployment for a left anterior descending coronary aneurysm complicated by late acute anterior myocardial infarction.
Circulation. 2005 Aug 2;112(5):e70-1. doi: 10.1161/CIRCULATIONAHA.104.497891.